HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.

AbstractAIM:
Transforming growth factor-β (TGF-β) is involved in renal tubulointerstitial fibrosis. Recently, the ubiquitin proteasome system was shown to participate in the TGF-β signalling pathway. The aim of this study was to examine the effects of proteasome inhibitors on TGF-β-induced transformation of renal fibroblasts and tubular epithelial cells in vitro and on unilateral ureteral obstruction (UUO) in vivo.
METHODS:
Rat renal fibroblasts NRK-49F cells and tubular epithelial cells, NRK-52E, were treated with TGF-β in the presence or absence of a proteasome inhibitor, MG132 or lactacystin. Rats were subjected to UUO and received MG132 i.p. for 7 days.
RESULTS:
In cultured renal cells, both MG132 and lactacystin inhibited TGF-β-induced α-smooth muscle actin (α-SMA) protein expression according to both western blotting and immunofluorescent study results. MG132 also suppressed TGF-β-induced mRNA expression of α-SMA and upregulation of Smad-response element reporter activity. However, MG132 did not inhibit TGF-β-induced phosphorylation and nuclear translocation of Smad2. In contrast, MG132 increased the protein level of Smad co-repressor SnoN, demonstrating that SnoN is one of the target molecules by which MG132 blocks the TGF-β signalling pathway. Although the proteasome inhibitor suppressed TGF-β-induced transformation of cultured fibroblasts and tubular epithelial cells, MG132 treatment did not ameliorate tubulointerstitial fibrosis in the rat UUO model.
CONCLUSION:
Proteasome inhibitors attenuate TGF-β signalling by blocking Smad signal transduction in vitro, but do not inhibit renal interstitial fibrosis in vivo.
AuthorsToru Sakairi, Keiju Hiromura, Satoshi Takahashi, Hiroko Hamatani, Shigeru Takeuchi, Mai Tomioka, Akito Maeshima, Takashi Kuroiwa, Yoshihisa Nojima
JournalNephrology (Carlton, Vic.) (Nephrology (Carlton)) Vol. 16 Issue 1 Pg. 76-86 (Jan 2011) ISSN: 1440-1797 [Electronic] Australia
PMID21175982 (Publication Type: Journal Article)
Copyright© 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology.
Chemical References
  • Actins
  • Cysteine Proteinase Inhibitors
  • Leupeptins
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Skil_v1 protein, rat
  • Smad Proteins, Receptor-Regulated
  • Smad2 Protein
  • Smad2 protein, rat
  • Smad3 Protein
  • Smad3 protein, rat
  • Smad4 Protein
  • Smad4 protein, rat
  • Transcription Factors
  • Transforming Growth Factor beta
  • smooth muscle actin, rat
  • lactacystin
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
  • Acetylcysteine
Topics
  • Acetylcysteine (analogs & derivatives, pharmacology)
  • Actins (genetics, metabolism)
  • Animals
  • Cells, Cultured
  • Cysteine Proteinase Inhibitors (pharmacology)
  • Disease Models, Animal
  • Epithelial Cells (cytology, metabolism)
  • Epithelial-Mesenchymal Transition (drug effects)
  • Fibroblasts (cytology, metabolism)
  • Fibrosis (genetics, metabolism)
  • Kidney Diseases (metabolism, pathology)
  • Leupeptins (pharmacology)
  • Male
  • Nerve Tissue Proteins (metabolism)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Wistar
  • Signal Transduction (drug effects, genetics)
  • Smad Proteins, Receptor-Regulated (metabolism)
  • Smad2 Protein (metabolism)
  • Smad3 Protein (metabolism)
  • Smad4 Protein (metabolism)
  • Transcription Factors (metabolism)
  • Transcription, Genetic (drug effects)
  • Transforming Growth Factor beta (drug effects, metabolism)
  • Ureteral Obstruction (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: